Posts Tagged ‘patient outcomes’

Treatment options impact patient outcomes more than age

30 Oct 2017 by under Research/Treatment

220px Effusionhalf1 100x100 Treatment options impact patient outcomes more than ageBecause has such a long latency period, it’s easy to assume that age plays a major factor in patient surgical outcomes. However, a new English study has found being older does not automatically reduce a patient’s odds of benefiting from surgery. (more…)


Inflammation prognostic indicator looks promising for mesothelioma patients

22 Sep 2017 by under News
Blausen 0676 Neutrophil crop 1 CREDIT BLAUSEN MEDICAL 100x100 Inflammation prognostic indicator looks promising for mesothelioma patients

Credit: Blausen Medical via Wikipedia

The neutrophil to lymphocyte ration (NLR) has been used as a prognostic indicator for patients with a number of cancers, but its benefits are still unclear for patients with malignant . is a cancer of the lining of internal organs caused by exposure. It is usually deadly within 12-18 months of diagnosis and has few effective treatment options, prompting researchers to continue to find ways to help treat the disease and measure the effectiveness of those treatments. (more…)


Study: Older pleural mesothelioma patients less likely to receive treatment

30 Aug 2017 by under Research/Treatment

220px Effusionhalf1 100x100 Study: Older pleural mesothelioma patients less likely to receive treatment has established a reputation for its long latency period. It can take 30-plus years to develop the cancer after initial exposure to , meaning a young person exposed to likely wouldn’t receive a diagnosis until he is a senior citizen. A recent study determined that the older a person with is, the less likely they are to receive treatment for the deadly cancer. (more…)


Breath test for mesothelioma may be a future diagnostic tool

13 Jun 2017 by under Research/Treatment

upper body 944557 960 720 100x100 Breath test for mesothelioma may be a future diagnostic toolBreathalyzers are a staple for testing the sobriety of swerving drivers on the road, and now researchers in Belgium are trying to make a similar breath test a staple in treatment. (more…)


Cholesterol medication may help reduce healthy cell death in mesothelioma patients

6 Jun 2017 by under Research/Treatment

shutterstock 380260327 edited 100x100 Cholesterol medication may help reduce healthy cell death in mesothelioma patientsA cholesterol-lowering medication may be able to pull double duty to help patients, according to a group of Japanese researchers. The drug, pravastatin, has been shown to reduce damage to healthy cells when given to mice with mesothelioma before treatments. (more…)


FitBits may be used to track mesothelioma patient outcomes

24 May 2017 by under Research/Treatment
Fitbit Charge HR 100x100 FitBits may be used to track mesothelioma patient outcomes

Credit: Wuefab/ Wikipedia

exposure can cause a wide range of health issues, from lung-scarring asbestosis to mesothelioma. Many treatments for -related diseases can require extensive surgeries, and a large part of stems from how well patients recover from surgery, especially in the case of invasive procedures like removing a lung.

A new study by the Pacific Heart, Lung and Blood Institute’s (PHLBI) Pacific Mesothelioma Center is using FitBit devices to monitor patients’ progress after surgery, according to a news release. (more…)


SMRP biomarker can indicate pleural mesothelioma patient outcomes

22 May 2017 by under Research/Treatment

587px Researcher looks through microscope 11 100x100 SMRP biomarker can indicate pleural mesothelioma patient outcomesWhen biomarkers occur at elevated levels in the blood, they typically indicate disease, and testing for specific biomarkers helps doctors determine from which disease a patient is suffering. New research has shown a biomarker long used to diagnose malignant may be a beneficial way to predict as well. (more…)


Elevated platelet count linked to negative peritoneal mesothelioma patient outcomes

7 Apr 2017 by under Research/Treatment

587px Researcher looks through microscope 1 100x100 Elevated platelet count linked to negative peritoneal mesothelioma patient outcomesThrombocytosis, a disorder that causes the body to produce too many blood platelets, has a negative impact on the success of a preferred treatment protocol for a number of patients, according to a new study by the University of School of Medicine. (more…)


Extrapleural pneumonectomy ‘clinically ineffective,’ group says

14 Mar 2017 by under Research/Treatment

lungs 1 002 100x100 Extrapleural pneumonectomy clinically ineffective, group saysA work group commissioned by the European Association for Cardio-Thoracic Surgery says enough evidence now exists to advise patients against (EPP). (more…)


Overall survival time is best clinical trial outcome measurement, study says

21 Feb 2017 by under Research/Treatment

598px Chemotherapy vials 3 100x100 Overall survival time is best clinical trial outcome measurement, study says Clinical trials are a vital part of medical testing, and their results determine treatment options for those diagnosed with an array of diseases. For those with , a deadly cancer caused by exposure to that affects the lining of the heart, lungs or abdomen, the results of clinical trials can determine how much longer a patient has to live.

A new study published in the journal The Oncologist stresses the important differences between two ways clinical trials determine outcomes for mesothelioma patients, according to Mesothelioma Research News. (more…)